Masayuki Fujinaga Selected Research

Masayuki Fujinaga Research Topics

Disease

10	Neoplasms (Cancer) 01/2023 - 04/2011
9	Neuroinflammatory Diseases 01/2021 - 05/2014
7	Breast Neoplasms (Breast Cancer) 10/2023 - 04/2011
7	Central Nervous System Diseases (CNS Diseases) 01/2022 - 07/2013
6	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 06/2014
4	Melanoma (Melanoma, Malignant) 01/2020 - 10/2014
3	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2019 - 01/2018
3	Schizophrenia (Dementia Praecox) 01/2019 - 01/2017
2	Parkinson Disease (Parkinson's Disease) 06/2020 - 01/2016
2	Substance-Related Disorders (Drug Abuse) 10/2019 - 01/2018
2	Inflammation (Inflammations) 01/2018 - 01/2014
2	Infarction (Infarctions) 01/2015 - 01/2011
2	Ischemia 09/2013 - 01/2011
2	Pneumonia (Pneumonitis) 01/2012 - 09/2011
1	Hypoxia (Hypoxemia) 07/2021
1	Tauopathies 10/2020
1	Obesity 01/2019
1	Epilepsy (Aura) 09/2018
1	Brain Diseases (Brain Disorder) 04/2018
1	Sarcoma (Soft Tissue Sarcoma) 01/2018
1	Status Epilepticus (Complex Partial Status Epilepticus) 11/2017
1	Glioma (Gliomas) 11/2017
1	Food Addiction 09/2017
1	Body Weight (Weight, Body) 01/2017
1	Pain (Aches) 01/2016
1	Liver Cirrhosis (Hepatic Cirrhosis) 11/2015
1	Fibrosis (Cirrhosis) 11/2015
1	Neoplasm Metastasis (Metastasis) 10/2014
1	Carcinogenesis 10/2014
1	Neuralgia (Stump Neuralgia) 06/2014
1	Nervous System Diseases (Neurological Disorders) 06/2014
1	Demyelinating Diseases (Demyelinating Disease) 06/2014
1	Brain Injuries (Brain Injury) 06/2014
1	Stroke (Strokes) 06/2014
1	Huntington Disease (Huntington's Disease) 04/2014
1	Non-alcoholic Fatty Liver Disease 11/2012

Drug/Important Bio-Agent (IBA)

21	Proteins (Proteins, Gene)FDA Link 10/2023 - 01/2011
10	LigandsIBA 01/2021 - 01/2011
6	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 10/2023 - 04/2011
6	metabotropic glutamate receptor type 1IBA 01/2023 - 01/2014
6	Biomarkers (Surrogate Marker)IBA 10/2020 - 01/2011
5	Glutamic Acid (Glutamate)FDA Link 01/2019 - 07/2013
3	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2023 - 11/2017
3	Oncogene Proteins (Oncogene Protein)IBA 01/2023 - 10/2014
3	Phosphotransferases (Kinase)IBA 06/2020 - 06/2012
3	N-methylbenzamideIBA 01/2020 - 09/2013
2	RadiopharmaceuticalsIBA 01/2023 - 01/2020
2	pyridineIBA 07/2021 - 01/2020
2	metabotropic glutamate receptor 2IBA 01/2019 - 01/2017
2	agerafenibIBA 01/2018 - 08/2014
2	Sorafenib (BAY 43-9006)FDA Link 01/2018 - 04/2011
2	acetamideIBA 11/2017 - 01/2014
2	Amyloid (Amyloid Fibrils)IBA 07/2016 - 08/2014
2	Peptides (Polypeptides)IBA 07/2016 - 08/2014
2	PhosgeneIBA 06/2012 - 12/2011
2	cobaltous chloride (cobalt(II)chloride)IBA 06/2012 - 12/2011
2	LipopolysaccharidesIBA 01/2012 - 09/2011
1	TARPIBA 01/2022
1	fluoromisonidazoleIBA 07/2021
1	Macrophage Colony-Stimulating FactorIBA 01/2021
1	2- tert- butyl- 4- chloro- 5- (6- (2- (2- fluoroethoxy)ethoxy)pyridin- 3- ylmethoxy)- 2H- pyridazin- 3- oneIBA 10/2020
1	Leucine (L-Leucine)FDA Link 06/2020
1	Radioisotopes (Radionuclides)IBA 01/2020
1	Monoacylglycerol LipasesIBA 10/2019
1	ElacridarIBA 02/2019
1	2- (4,5- dihydro- 1H- imidazol- 2- yl)- 1- methyl- 1H- indoleIBA 01/2019
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2019
1	AMPA Receptors (AMPA Receptor)IBA 09/2018
1	AcidsIBA 09/2018
1	N,N-diethylacetamideIBA 04/2018
1	2- (7- butyl- 2- (4- (2- (((18)F)fluoroethoxy)phenyl)- 5- methylpyrazolo(1,5- a)pyrimidin- 3- yl)- N,N- diethylacetamideIBA 04/2018
1	Therapeutic UsesIBA 04/2018
1	EndocannabinoidsIBA 01/2018
1	Pilocarpine (Ocusert)FDA LinkGeneric 11/2017
1	Ghrelin ReceptorsIBA 09/2017
1	Glucose (Dextrose)FDA LinkGeneric 09/2017
1	Carbon-11IBA 07/2016
1	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 07/2016
1	anandamide (arachidonylethanolamide)IBA 01/2016
1	alpha-SynucleinIBA 01/2016
1	CannabinoidsIBA 01/2016
1	Carbon Tetrachloride (Tetrachloromethane)IBA 11/2015
1	EnzymesIBA 08/2015
1	Glycogen Synthase KinasesIBA 08/2015
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 08/2014
1	imidazopyridineIBA 08/2014
1	hydroxyfasudilIBA 06/2014
1	rho-Associated KinasesIBA 06/2014
1	N- methyl- N- (1- phenylethyl)- 2- propynylamineIBA 05/2014
1	Neuroprotective AgentsIBA 09/2013
1	PK 11195 (PK11195)IBA 11/2012
1	Choline (Choline Chloride)IBA 11/2012
1	nasIBA 11/2012
1	Methionine (L-Methionine)FDA Link 11/2012
1	Urea (Carbamide)FDA LinkGeneric 06/2012
1	Proteasome Endopeptidase Complex (Proteasome)IBA 06/2012

Therapy/Procedure

3	Therapeutics 01/2023 - 01/2016
1	Drug Therapy (Chemotherapy) 08/2021
1	Intravenous Injections 01/2020
1	Oral Administration 01/2017